Pharmaceutical Industry Trends & News - Pharmaceutical Technology

PremiumNews

Beijing unveils blueprint for biomedical dominance by 2030

Outlining a five-year biomedical plan, China wants to expand its global role beyond just pipeline innovation.

Robert Barrie

News

Telix to acquire ITM in deal worth up to $2.35bn

Salong Debbarma

News

Sandoz and mAbxience agree on emicizumab biosimilar partnership

Salong Debbarma

News

FDA approves first gene therapy for Sanfilippo syndrome type A

PremiumAnalyst Comment

FDA hearing: psychedelics launch needs balanced regulation without limiting access

News

Novo targets oral macrocycles with $1.4bn Orbis partnership

News

Roche agrees to $1bn deal with Dualitas for bispecific antibody research

PremiumFeatures

The shrinking return on investment for Nordic innovation

Analysis

PremiumAnalyst Comment

Looking beyond short-term turmoil, Syngene is investing for the future

Dominic Tyer

PremiumAnalyst Comment

ERS 2026: obesity, an independent obstruction to biologic-treated asthma

GlobalData Healthcare

PremiumAnalyst Comment

ERS 2026: BMI, type-2 inflammation, and asthma attack risk

GlobalData Healthcare

PremiumFeatures

Staunch biotech competition spurs new secretive tactics, shifts investor approach

Annabel Kartal Allen

Themes

Partner Content

How DFE Pharma supports confident continuous manufacturing decisions

Continuous manufacturing (CM) is increasingly being evaluated to integrate unit operations, enable closer process monitoring and reduce the intermediate handling and hold steps associated with conventional batch production. Realising those...

More themes

Partner Content

Industry partnership will determine the success of the transition to low-GWP pMDIs

News

Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory

Partner Content

Turning AI skeptics into AI advocates through high-integrity data

Partner Content

Keeping pace with generative AI in pharmaceutical and healthcare organisations

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Small-Cell Lung Cancer (SCLC): Market View, Current and Future Competitive Landscape

$3495.00

Hodgkin Lymphoma: Epidemiology Report and Forecast

$9995.00

Glioblastoma (GBM): Epidemiology Report and Forecast, 2026

$9995.00

Narcolepsy Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

$17995.00

Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2026

$3450.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

Telix to acquire ITM in deal worth up to $2.35bn

Sandoz and mAbxience agree on emicizumab biosimilar partnership

FDA approves first gene therapy for Sanfilippo syndrome type A

FDA hearing: psychedelics launch needs balanced regulation without limiting access

Novo targets oral macrocycles with $1.4bn Orbis partnership

Roche agrees to $1bn deal with Dualitas for bispecific antibody research

The shrinking return on investment for Nordic innovation

Looking beyond short-term turmoil, Syngene is investing for the future

ERS 2026: obesity, an independent obstruction to biologic-treated asthma

ERS 2026: BMI, type-2 inflammation, and asthma attack risk

Staunch biotech competition spurs new secretive tactics, shifts investor approach

How DFE Pharma supports confident continuous manufacturing decisions

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

Small-Cell Lung Cancer (SCLC): Market View, Current and Future Competitive Landscape

Hodgkin Lymphoma: Epidemiology Report and Forecast

Glioblastoma (GBM): Epidemiology Report and Forecast, 2026

Narcolepsy Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

Small-Cell Lung Cancer (SCLC): Market View, Current and Future Competitive Landscape

Hodgkin Lymphoma: Epidemiology Report and Forecast

Glioblastoma (GBM): Epidemiology Report and Forecast, 2026

Narcolepsy Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing